Clofibrate, for a long time in use as a hypolipidemic drug, is a well known peroxisomal proliferator (PP) and hepatocarcinogen in rodents. We show here that in vitro 1 mM clofibrate induces a rapid and massive death of rat AH-130 hepatoma cells. Cell death was prominent already after 4 h of treatment, with a characteristic`apoptotic' pattern by conventional microscopy. This was further supported by the pronounced chromatin condensation detectable on 4',6-diamine-2'-phenylindole dihydrochloride (DAPI) staining, the clearcut internucleosomal DNA fragmentation on agarose-gel electrophoresis (ladder patten), and the accumulation of markedly hypochromic cells observed in flow cytometric DNA histograms. Consistently with the apoptotic features of the process, some parameters commonly used to detect cell death, such as plasma membrane permeabilization to trypan blue or propidium iodide, lack of mitochondrial retention of rhodamine 123, or extracellular release of lactate dehydrogenase, were all virtually negative. However, these same parameters became markedly positive after 24 h of treatment, which was suggestive for the occurrence of`secondary' necrosis among AH-130 cells. By a combination of flow cytometric parameters, after 4 h on 1 mM clofibrate only 41% of the AH-130 cells could still be categorized as viable (i.e., non-apoptotic and non-necrotic), while 46% of cells appeared apoptotic and 13% necrotic. At 24 h, 67% of cells were necrotic, 20% apoptotic and only 13% non-apoptotic and nonnecrotic. Apoptosis was also extensive in AH-130 cells treated with another PP such as nafenopin at 1 mM concentration and in human hepatoma HepG2 cells treated with clofibrate. By contrast, clofibrate did not cause apoptosis on primary rat hepatocyte cultures. These observations indicate that: (i) apart from their well-known cell growth-promoting action, PPs such as clofibrate or nafenopin may exert a substantial cytotoxic action on targets such as the AH-130 or HepG2 hepatoma cells; (ii) this cell death evolves from an initial apoptotic' to an eventual`necrotic' pattern; (iii) detection of cell death requires the adoption of a full panel of tests, adequate to cover the whole evolving death pattern, while such tests may even be substantially misleading whenever applied individually; (iv) the cytotoxicity of clofibrate and similar agents on normal and, particularly, tumoural cells may deserve careful reevaluation.
Introduction
The carcinogenic action of PPs is widely documented. Since PPs do not damage DNA directly, these agents are usually categorized as nongenotoxic carcinogens (e.g. Reddie and Lalwai, 1983; Bursch et al, 1992; Chen et al, 1994 ). Yet genotoxicity may arise indirectly, due to excess reactive oxygen species and lipid peroxidation products generated in consequence of the PP-induced elevation of peroxisomal boxidation enzymes; of special importance, in this connection, is fatty acyl-CoA oxidase, which has hydrogen peroxide as a byproduct (Reddie and Lalwai, 1983; Hwang et al, 1993) . The induction of these enzymes, as well as of the microsomal cytochrome P450 IVA or of the mitochondrial HMGCoA synthase (Rodriguez et al, 1994) , is specifically mediated by the PPAR. This is a member of the steroid hormone receptor superfamily that recognizes PP-response elements in the upstream promoter region of the responsive genes and thereby activates their transcription (reviewed in Green and Wahli, 1994) . The action as tumour promoters is most often ascribed to enhanced liver cell proliferation (Reddie and Lalwai, 1983; Chen et al, 1994 , and references therein). PPs may indeed stimulate cell growth in vivo (Ohmura et al, 1996) . In cells of the hepatocytic lineage mitogenesis by amphipathic carboxylates, the main PP class that includes clofibrate, specifically involves their interaction with the liver fatty acidbinding protein (Khan and Sorof, 1994 , and references therein). An additional mechanism, not necessarily alternative, stems from the observation that cell death by apoptosis in preneoplastic or early neoplastic liver lesions is suppressed by a variety of tumour promoters, including PPs (SchulteHermann et al, 1987; Bursch et al, 1992; Columbano et al, 1996) . Consistently, a PP such as nafenopin (50 mM) has recently been reported to promote the survival of cells of the hepatocytic lineage in vitro (Bayly et al, 1994; Gill et al, 1995) .
In the course of experiments aimed at altering the lipid composition of tumour cells, we found, unexpectedly, that 1 mM clofibrate induced rapid and massive death of Yoshida AH-130 ascites hepatoma cells in vitro. The same result was obtained on human hepatoma HepG2 cells, while only AH-130 cells were killed by another PP, nafenopin, at 1 mM concentration. Clofibrate, discovered some 30 years ago (Thorp and Waring, 1962) , has long been in use as a hypolipidemic drug (briefly reviewed in Hahn and Goldberg, 1992) . The mechanism of the hypolipidemic action of clofibrate or other fibric acid derivatives, some still of clinical relevance, is not yet clear (Hahn and Goldberg, 1992; Green and Wahli, 1994) . In the liver of rodents, clofibrate and other PPs cause conspicuous increases in size and number of peroxisomes, hyperplasia and hepatocellular carcinomas (Reddie and Lalwai, 1983) .
In the present paper, we report on the death of rodent and human hepatoma cells by clofibrate and nafenopin, show that it occurs by the apoptotic mode, and briefly discuss the possible relevance of this finding to the action of clofibrate and related agents as tumour promoters. In addition, the present data, further expanding previous observations and concepts (Darzynkiewicz et al, 1992; Dive et al, 1992) , suggest that this clofibrate-induced cell death can be proposed as a useful model to illustrate the relative merit and reliability of a panel of procedures commonly employed in cytotoxicity testing.
Results

Microscopy
The basic morphological changes occurring in AH-130 cells exposed to 1 mM clofibrate are illustrated in Figure 1B and C. Cell shrinkage due to nuclear and cytoplasmic condensation was clearly detectable at 4 h and involved a substantial fraction of the population by 24 h. As observed after DAPIstaining, a striking pattern of chromatin condensation associated with polylobation or fragmentation of nuclei was already prominent by 4 h. A similar pattern was observed when AH-130 cells were incubated in the presence of 1 mM nafenopin ( Figure 1D ).
After 4 and 24 h incubation, the percentage of apoptotic cells (apoptotic index, data not shown) amounted to 48 and 95%, respectively, for cells treated with 1 mM clofibrate and to 37 and 94%, respectively, for those on 1 mM nafenopin. Lower concentrations of either drug (0.05 mM) did not cause any appreciable increase of the apoptotic index over the values recorded for controls, incubated with the solvents alone (2 and 8% at 4 and 24 h, respectively).
Moreover, at variance with its previously reported action on rat hepatocytes or FaO hepatoma cells (Bayly et al, 1994; Gill et al, 1995) , 0.05 mM nafenopin did not display any protective effect on AH-130 cells against apoptosis either spontaneous or induced by 1 mM clofibrate. The cytotoxicity of clofibrate was also assessed on other cell types. No apoptosis was caused by this drug, at concentrations up to 1 mM, in primary cultures of rat hepatocytes (data not shown). By contrast, 1 mM clofibrate was clearly apoptogenic for human hepatoma HepG2 cells ( Figure 2B ; the percentage of cells with a 52n DNA fluorescence, by flow cytometry, was 1% at time 0, 5% at 2 h, 19% at 4 h, 26% at 8 h). The HepG2 cells, however, were not affected by treatment with 1 mM nafenopin. 
DNA electrophoresis
Cleavage of nuclear DNA into multiples of 180 ± 200 bp, detectable as`DNA laddering' by AGE, is usually considered a hallmark of apoptosis (reviewed in Peitsch et al, 1994) . Analysis of the DNA extracted from clofibrate-treated AH-130 cells showed (Figure 3 ) a clearcut ladder pattern at both 4 and 24 h, the extent of DNA fragmentation increasing with exposure time and clofibrate concentration. Although in some systems such internucleosomal chromatin cleavage is not detectable, its occurrence confirms the apoptotic nature of the process.
Flow cytometry
The death process elicited by clofibrate in AH-130 cells was analyzed in detail flow cytometrically (cf. Darzynkiewicz et al, 1992; Dive et al, 1992) . At 4 h, the onset of apoptosis was associated with an increased SSC of cells, in agreement with previous observations (Swat et al, 1991; Barbiero et al, 1995) , though basal SSC levels had recovered by 24 h (not shown). Figure 4 illustrates the distribution of DNA fluorescence vs FSC, a parameter for cell size. In control cells, the pattern after 24 h in vitro was similar to that observed at time 0 or after a 4 h incubation (not shown). In cells exposed to 1 mM clofibrate, flow cytometry detected a substantial accumulation of cells characterized by a 52n DNA fluorescence (in the A0 region, according to Telford et al, 1991) . Already prominent after a 4 h treatment, when it accounted for 41+7% of cells, this subpopulation became even more conspicuous by 24 h (63+8%), when also the FSC was decreased. A further peak, well distinct from the A0 region, was evident at 24 h (Figure 4, right): characterized by very low FSC and faint PI staining, it represented debris from necrotic cells (cf. Darzynkiewicz et al, 1992; Dive et al, 1992) . Figure 5 illustrates how the distribution of AH-130 cells treated with 1 mM clofibrate evolved with respect to two other parameters evaluated on non-fixed cells, namely, SSC, which reflects`cell density', and PI exclusion, as a measure of plasma membrane integrity. SSC was substantially increased at 4 h, as often observed in apoptosing cells (Swat et al, 1991; Barbiero et al, 1995) , though by 24 h it had largely receded to control levels. Figure 5 further shows that PI, while excluded by virtually all of the control cells and by most of those treated with 1 mM clofibrate for 4 h, was taken up by the vast majority of cells after 24 h on clofibrate; this finding argues for the occurrence of`secondary necrosis' among AH-130 cells (Wyllie et al, 1980; Desjardins and MacManus, 1995) .
As a further viability test, R123 mitochondrial retention in AH-130 cells was evaluated by flow cytometry (not shown). This parameter closely correlated with PI-exclusion in both control and experimental cells. On 1 mM clofibrate, cells that did not retain R123 were 414% at 4 h, but amounted to 465% by 24 h. In other models of apoptosis reviewed in Kroemer et al, 1995) the integrity of mitochondria is compromised earlier than that of the plasma membrane or of lysosomes (by acridine orange retention).
The overall information obtained by flow cytometry is summarized in Figure 6 . As detailed in the legend, combining different flow cytometric parameters (DNA fluorescence, FSC, SSC, PI exclusion, R123 retention) permitted to discriminate among viable (neither necrotic nor apoptotic), early apoptotic, and late apoptotic AH-130 cell subpopulations. Control cells were virtually all viable at 4 h, and still 490% viable by 24 h. On 1 mM clofibrate, not more than 41% of the population could be considered viable by 4 h, and only 13% by 24 h, which figures are pretty close to those obtained microscopically by counting the proportion of apoptotic cells (see above). It is clear, though, that at 4 h most dying cells were still at an early stage of the apoptotic process, and only a few (13%) at a late stage, whereas by 24 h two-thirds of the cells were at a late apoptotic stage.
Conventional cell integrity parameters
The effect of clofibrate on AH-130 cell integrity was further evaluated by two routine procedures, namely TB exclusion and LDH release (Tables 1 and 2 ). In controls or in cells incubated with 0.05 or 0.25 mM clofibrate at both 4 and 24 h, only a negligible fraction of cells failed to exclude the dye. By contrast, on 1 mM clofibrate the proportion of cells stained by TB at 4 h increased moderately, while about 70% of the cells became permeable to TB by 24 h. Moreover, a significant decrease of cell number was observed only after 24 h treatment with 1 mM clofibrate (Table 3) . These figures are consistent with those obtained flow-cytometrically with the PIexclusion test (see Figures 4 and 5) .
Although basically similar, the LDH release data (Table  2 ) indicate a degree of damage slightly higher than that measured by TB-exclusion testing. At first sight, this may appear surprising for a small molecule such as TB (or PI) should cross a`leaky' plasma membrane much more easily than LDH. However, the results of simple counts showed that in 24 h 1 mM clofibrate caused a 14% decrease in the total number of cells. Since this change presumably reflected, in part at least, complete disintegration of a significant proportion of cells, the corresponding contribution of LDH to the medium probably accounted for the excess cell death measured by LDH release vs the values detected by TB-exclusion testing.
TB exclusion and LDH release were also evaluated on cells exposed to nafenopin (Tables 1 and 2 ). The results with 0.05 mM nafenopin at 4 and 24 h (data not shown) and with 1 mM nafenopin at 4 h closely reproduced those obtained with clofibrate at corresponding concentrations and times. By contrast, leakiness to TB and LDH release were both markedly lower after 24 h on 1 mM nafenopin than on clofibrate and, consistently, the number of nafenopin-treated cells did not decrease significantly (data not shown).
Discussion
The present observations show that clofibrate and nafenopin were rapidly and extensively lethal for rat ascites hepatoma AH-130 cells in vitro. Also the HepG2 cells, a human hepatoma line, were rapidly killed by clofibrate, though less extensively than the AH-130 cells, but nafenopin had no lethal action on them. Other rat hepatoma cells (JM2 and Morris 7777, unpublished observations) or rat hepatocytes in primary culture were not affected by clofibrate. This induced cell death, which occurred by apoptosis, was particularly investigated on clofibrate-treated AH-130 cells.
Clofibrate was apoptogenic at 1 mM, which apparently is a quite high concentration; however, similar or even higher concentrations have been used in biochemical studies on tissue cultures (Chawla and Lazar, 1994; Perrot et al, 1991) , and 250 mg/kg b.w. is a usual dosage for clofibrate in rat chemical hepatocarcinogenesis protocols (cf. Reddy and Lalwai, 1983) .
The death process in AH-130 cells
Apoptosis is the mode by which the AH-130 cells spontaneously die in the animal at rates that increase as the tumour shifts from the exponential to the plateau growth phase . In AH-130 cells treated with 1 mM clofibrate, apoptosis was already prominent after 4 h and became massive by 24 h. Cell death was easily detected by light microscopy, on smears stained with haematoxylin and eosin or DAPI, as well as by flow cytometry, from the appearance of a subpopulation of cells with a 52 n DNA fluorescence. Such hypodiploid peak or A0 region in the cytogram correlated with the occurrence of a clearcut internucleosomal DNA fragmentation, as detected by AGE (see Nicoletti et al, 1991; Telford et al, 1991) . At 4 h, the onset of apoptosis was associated with an increased SSC of cells, in agreement with previous observations (Swat et al, 1991; Barbiero et al, 1995) , though basal SSC levels had recovered by 24 h, most cells had shrunk to a smaller size, as that is non-apoptotic and non-necrotic: with normal SSC, excluding PI, retaining R123, and outside the A0 region; (2) early apoptotic (open bars): with increased SSC, excluding PI, retaining R123, and included in the A0 region; (3) late apoptotic (full bars): with normal SSC, not excluding PI, not retaining R123, and included in the A0 region (`secondary necrosis', Wyllie et al, 1980) . Data expressed as percentages of total cells (means of three experiments). Differences between means were statistically significant (p50.05) on ANOVA followed by Newman-Keuls test. also denoted by the decreased FSC, and had generally progressed to more advanced stages of the apoptotic process. Notably, after 4 h on 1 mM clofibrate virtually all cells appeared`viable' by conventional tests for cell necrosis that measure either the leakiness of plasma membranes to dyes such as trypan blue (by light microscopy) and propidium iodide (by flow-cytometry) or the extracellular release of cytoplasmic constituents such as LDH. Therefore, these tests almost totally failed to diagnose an already conspicuous cell death process, which, by contrast, was clearly detected using appropriate procedures that have been recently developed to monitor and quantify apoptosis. By 24 h, cell death was also demonstrated with conventional tests for cell necrosis. Flow cytometric techniques were particularly apt to monitor the death process, for they rapidly discriminated between apoptotis and necrosis or between early and late stages of apoptosis in the whole cell population (Darzynkiewicz et al, 1992; Dive et al, 1992) . However, once dead cells had fully disintegrated, death could only be measured by a test such as the LDH release assay. Of interest, the development of such secondary changes was far less pronounced when apoptosis was elicited by 1 mM nafenopin, as consistently shown by all the parameters measured (apoptotic index, TB exclusion, LDH release). The reason for such a difference remains obscure, however. By all evidence, clofibrate or nafenopin caused death in AH-130 cells mainly by the apoptotic mode, while only subsequently the apoptosed cells, particularly those exposed to clofibrate, underwent changes that can be conventionally categorized as`secondary necrosis' (Wyllie et al, 1980; Desjardins and MacManus, 1995) .
Mechanisms of the lethal action of clofibrate and nafenopin
An analysis of the mechanism(s) underlying the apoptogenic action of clofibrate and nafenopin on the rat AH-130 cells and the reason why the human HepG2 cells were only susceptible to clofibrate is beyond the scope of the present report, and can only be conjectural thus far.
Among the pleiotropic effects of clofibrate, shared with nafenopin only in part, many are potentially relevant to induction of apoptosis. Suppression of DNA and RNA synthesis (Parekh and Chitins, 1991) or inhibition of HMGCoA reductase (Castillo et al, 1990; Haughom and Spydevold, 1992 ) might well play a role, since apoptosis may be caused by inhibitors of macromolecular syntheses (e.g. Hickman, 1992; Amenta et al, 1993; Sherwood and Schimke, 1994; Barbiero et al, 1995) or by the HMGCoA reductase inhibitor lovastatin (e.g. Bansal et al, 1991; Pe Â rez-Sala and Molinedo, 1994; Han and Wyche, 1996) . Also, neither the action of clofibrate as enzyme inducer (see Introduction) nor the suggestion that PP toxicity may result from PPAR interferring with retinoid action (Green and Wahli, 1994) can be disregarded. The status of the PPAR expression in the different cells herewith tested is currently under investigation and we ignore whether it is related to the present differential effects. However, the rapidity of the lethal effect of clofibrate on AH-130 or HepG2 cells might be difficult to reconcile with the possibility of an involvement of the PPAR. On the other hand, clofibrate and other PPs are known to exert antiproliferative and differentiation-promoting effects on cells such as 3T3-L1 preadipocytes (Chawla and Lazar, 1994) and, in normal rat liver, clofibrate can stimulate the production of TGF-b (Rumsby et al, 1994) , which is a known inhibitor of growth and inducer of apoptosis on rodent hepatocytes or rodent and human hepatoma cells (Lin and Chou, 1992; Bursch et al, 1993; Fukuda et al, 1993) .
Nafenopin at 0.05 mM concentration has been recently shown to suppress apoptosis, whether spontaneous or elicited by agents such as TGF-b, and to promote cell survival of primary hepatocyte cultures and cells of the FaO rat hepatoma line (Bayly et al, 1994; Gill et al, 1995) . On the AH-130 cells, not only we did not observe any protection of 0.05 mM nafenopin against spontaneous or clofibrate-induced apoptosis, but, rather, 1 mM nafenopin Values expressed as 10 4 cells/ml suspension; a 400 was the seeding density and thus is the time 0 ®gure for all groups. Presentation and statistical analysis of data as in Table 1. was as apoptogenic as clofibrate. Whether the reason for such divergent effects pertains to the cell type is not known as yet and deserves further investigations.
Possible significance of the lethal action of clofibrate
Two apparently contradictory effects have been reported for PPs as tumor promoters. Short-term treatment consistently causes a decrease in the number and size of glutathione Stransferase P1-1 or g-glutamyltranspeptidase-positive preneoplastic lesions, whereas longer treatment results in more and larger tumors in livers with the same preneoplastic lesions (Chen et al, 1994 , and references therein). The phenotypic shifts observed in preneoplastic hepatic lesions in response to short-term treatment with PP may reflect inhibition of certain subsets of cell populations and promotion of others (Chen et al, 1994) . Whether changes in rates of cell proliferation or of cell deletion or of both processes are involved is not entirely clear. In the course of chemical carcinogenesis, preneoplastic liver lesions are known to undergo extensive remodelling and cell turnover (Columbano et al, 1984; Rotstein et al, 1986; Bursch et al, 1992; Canuto et al, 1993; Chen et al, 1994; Piga et al, 1995) , implying that they contain a significant proportion of cells whose survival is compromised. Under such circumstances, additional stimulation with a PP could further upset the finely-tuned balance of extra-and intracellular signals, to such an extent as to precipitate cell death (Wyllie, 1992; Passilly et al, 1996) .
Irrespective of the precise underlying mechanism(s), the observation that clofibrate exerts strong lethal action on cells of both rodent and human origin such as the AH-130 and the HepG2 suggests that the cytotoxicity of clofibrate and related agents on normal and, particularly, tumoural cells may deserve careful reevaluation.
Materials and methods
Cells and treatments
Male Long-Evans rats, weighing 120 ± 150 g and maintained on a semi-synthetic diet (Piccioni, Brescia, Italy) and water ad libitum were used for serial weekly transplantation of the Yoshida AH-130 ascites hepatoma (20 ± 30610 6 tumour cells inoculated i.p. in 1 ml). Under sterile conditions, 6 day-old ascites tumours were collected with a syringe and cells were separated from the ascitic fluid by low-speed centrifugation, washed in RPMI 1640 medium, resuspended (4610 6 / ml) in the same medium supplemented with 10% newborn calf serum, 1% (w/v) bovine serum albumin (fraction V, fatty acid free), and transferred to Petri dishes.
Rat hepatocytes were isolated according to standard procedures (Seglen, 1973) and cultured as indicated by Bayly et al. (1994) . HepG2 cells, derived from a human hepatoblastoma, were grown in DMEM supplemented with 10% foetal calf serum in standard conditions. Clofibrate, dissolved in dimethylsulphoxide, or nafenopin, dissolved in N-N-dimethylformamide, were added (1 : 100 in volume) to culture media to the final concentrations specified. Controls were treated with solvents alone. HepG2 cells were incubated for 2 ± 4 ± 8 h and the other cells for 4 or 24 h at 378C in a humidified atmosphere of 5% CO 2 in air, then harvested and analyzed.
DNA distribution
DNA staining was performed as described elsewhere , with some modifications (Bianciotto et al, 1995) . Briefly, cells were washed in PBS, fixed in ice-cold 70% ethanol for at least 30 min, incubated at room temperature in PBS containing DNase-free RNase (Type II-A) and PI at final concentrations of 0.4 and 0.18 mg/ml, respectively, then analyzed with a FACScan flow cytometer (Becton & Dickinson, Mountain View, CA, USA) equipped with a 488 nm argon laser and two filters, respectively transmitting at 585 nm (FL2) and above 620 nm (FL3). FSC and SSC were measured simultaneously. Data were recorded on a Hewlett Packard computer (HP 9000, model 300), using CellFit software (Becton & Dickinson).
Cell integrity
A panel of independent parameters was used.
Plasma membrane integrity was checked both microscopically and flow cytometrically. TB exclusion was evaluated on cells suspended in the presence of the dye (0.8 mg/ml); 400 cells were counted for each sample and results expressed as percentages of TB-positive cells. For the PI-exclusion test, cells unfixed and suspended in PBS (10 6 cells/ ml) were incubated with PI (10 mg/ml) and analyzed by flow cytometry as detailed elsewhere .
Mitochondrial transmembrane potential was evaluated by a R123-retention test. Unfixed AH-130 cells suspended in PBS (10 6 cells/ml) were incubated for 30 min 378C with R123 (10 mg/ml) and analyzed by flow cytometry as described elsewhere . In some experiments cells were both preincubated with R123 and subsequently stained with PI, as specified above, to compare PI exclusion and R123 retention.
LDH activity was assayed (Kornberg, 1955) on total cell suspensions, after sonication, and on clear supernatants after centrifugation at 6006g for 10 min. The activity determined in the supernatant was expressed as percentage of total activity in the cell suspension.
DNA fragmentation
The occurrence of internucleosomal DNA fragmentation was evaluated by the AGE method as described by Kaufmann (1989) . Cells were washed twice with ice-cold phosphate-buffered saline, suspended at 2610 6 cells/ml in a lysis buffer (2 mM EDTA, 10 mM NaCl, 1% sodium dodecyl sulphate, 500 mM Tris-HCl, pH 9.0), incubated with RNAse (20 mg/ml) for 1 h at 378C and then with proteinase K (100 mg/ml) for 1 h at 378C, and finally extracted with phenol/chloroform. Aliquots of 10 mg DNA were electrophoresed on a 1.0% agarose gel and viewed under UV illumination after staining with ethidium bromide (0.5 mg/ml).
Light microscopy
Cells were fixed in methanol, stained with the DNA-specific fluorochrome DAPI and examined in an epiilluminated fluorescence microscope (Dialux, Leitz, Germany). The apoptotic index (percentage of apoptotic cells) was determined on at least 1000 cells per sample.
Statistical analysis
Data are expressed as means+SD. Significance of differences was assessed by ANOVA, followed by the Newman-Keuls test.
